ReviewEndocrine, metabolic & immune disorders drug targets2026
Medication De-escalation in Type 2 Diabetes: A Review of Evidence-Based Strategies for Combination Therapy Reduction.
Omar OraibiPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.